Consensus Viracta Therapeutics, Inc.

Equities

Delayed Nasdaq Other stock markets 10:15:04 06/05/2024 pm IST			5-day change	1st Jan Change
0.8391 ^USD	+3.57%		+2.20%	+47.21%

15/04	Viracta Therapeutics, Inc. Reports Positive Topline Results from Stage 1 of the Pivotal Phase 2 NAVAL-1 Trial	CI
01/04	Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan	CI

d23782eda47d.q4ttZyjo5ah93wOQlE87gtdrdiZ2lNkJ9r3yr5LLtoo.-9oCMF67od5QhWb8rX5s7qUFTxAC3rFfkdmW9si-hr-f3gc0RqPWmR7maA~622409e9aad4c87d512c10da0f12e5e0

RBC Cuts Price Target on Viracta Therapeutics to $6 From $7, Keeps Outperform, Speculative Risk	10/11	MT
HC Wainwright Lowers Price Target on Viracta Therapeutics to $10 From $33, Maintains Buy Rating	05/23/05	MT
RBC Cuts Price Target on Viracta Therapeutics to $7 From $8, Maintains Outperform, Speculative Risk Rating	09/23/09	MT
Oppenheimer Adjusts Viracta Therapeutics Price Target to $16 From $14, Maintains Outperform Rating	27/23/27	MT
RBC Cuts Price Target on Viracta Therapeutics to $8 From $10, Maintains Outperform, Speculative Risk	11/22/11	MT
History shows stocks can weather rate hike cycle	16/22/16	RE
Viracta Therapeutics Initiated at Outperform by RBC With Speculative Risk Qualifier, Price Target Started at $10/Share	01/22/01	MT
Viracta Says Epstein-Barr Therapy Had 40% Overall Response Rate in Trial; Shares Fall	14/21/14	MT
VIRACTA THERAPEUTICS : HC Wainwright Starts Viracta Therapeutics at Buy With $35 Price Target	03/21/03	MT
VIRACTA THERAPEUTICS : SVB Leerink Initiates Viracta Therapeutics at Outperform With $18 Price Target	26/21/26	MT
VIRACTA THERAPEUTICS : Evercore ISI Starts Viracta Therapeutics at Outperform with $45 Price Target	25/21/25	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.8102 USD

Average target price

7 USD

Spread / Average Target

+763.98%

High Price Target

13 USD

Spread / Highest target

+1,504.54%

Low Price Target

4 USD

Spread / Lowest Target

+393.71%